Product Images Budesonide
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Budesonide NDC 0093-6817 by Teva Pharmaceuticals Usa, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
budesonide structural formula - image 1
1 - image 10
This is a medication called Budesonide Inhalation Suspension. Each unit-dose ampule delivers 2 mL of a sterile suspension containing 1 mg of micronized budesonide. It is for oral inhalation use only and not for injection. The medication comes in 6 pouches with 5 2 mL ampules each, for a total of 30 unit-dose ampules. It should only be used in a jet nebulizer and not in an ultrasonic nebulizer. The inactive ingredients include citric acid monohydrate, disodium edetate, polysorbate 80, sodium chloride, tri-sodium citrate dihydrate, and water for injection. The medication is manufactured in England by Norton Healthcare Limited and brought to the United States by Teva Pharmaceuticals USA, Inc. The lot/exp coding area is available.*
Figure 1: A 12 Week Trial in Pediatric Patients Not on Inhaled Corticosteroid Therapy Prior to Study Entry. Nighttime Asthma Change From Baseline. - image 2
The text is describing a clinical trial for a medication aimed at reducing nighttime asthma symptoms. The trial measured the mean change from baseline symptoms over a 12-week period, with patients taking either placebo, 0.25mg, 0.5mg, or 1.0mg once daily. The p-values for each dose were also provided.*
Figure 2: A 12 Week Trial in Pediatric Patients Previously Maintained on Inhaled Corticosteroid Therapy Prior to Study Entry. Nighttime Asthma Change From Baseline. - image 3
Figure 3: A 12 Week Trial in Pediatric Patients Either Maintained on Bronchodilators Alone or Inhaled Corticosteroid Therapy Prior to Study Entry. Nighttime Asthma Change From Baseline. - image 4
This appears to be a table or a chart showing the mean change from baseline nighttime asthma symptoms for different doses of a medication over a period of 12 weeks. The medication was compared to a placebo. The text notes the different doses and their frequency, as well as the p-values for each dose.*
Figure 1 - image 5
Figure 2 - image 6
Figure 3 - image 7
Figure 4 - image 8
1 - image 9
This is a set of instructions for the proper use and storage of Budesonide Inhalation Suspension. The user is advised to follow instructions given by a physician and not to discard the foil envelope until all ampules are used. The user should also use the contents of an ampule immediately after opening it. The unopened ampules should be stored upright in the carton in the foil envelope and protected from light. The instructions provide a step-by-step guide on how to use the product and direct the user to refer to the enclosed Patient Instructions.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.